ENYO Pharma Alternatives & Competitors
12 companies similar to ENYO Pharma — Developing therapeutics for diseases with impaired kidney function
Companies similar to ENYO Pharma
ILIAS Biologics Inc.
The Global Leader in Exosome-based Therapeutics
Korea South
KAMADA
Specialty Plasma-Derived Therapeutics
Rehovot, Israel
GENFIT
Dedicated to improving the lives of patients with liver diseases characterized by high unm...
Loos, France
AusperBio
Transforming Patient Lives For a Better Tomorrow
San Mateo, United States
Track all ENYO Pharma competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
-(ACHFF:OTCQB)-logo.jpg "Arch Biopartners Inc (ARCH:TSXV) (ACHFF:OTCQB)"){kind=logo}
Arch Biopartners Inc (ARCH:TSXV) (ACHFF:OTCQB)
A late stage clinical trial company focused on the development of novel therapeutics targe...
Toronto, Canada
REGENXBIO
Seeking to improve lives through the curative potential of gene therapy.
Rockville, United States
Biodexa Pharmaceuticals PLC
Advancing Medicines for a Brighter Future
Cardiff, United Kingdom
Emmaus Life Sciences, Inc
Improving the lives of people with rare disease.
Torrance, United States
DevsHealth
At DevsHealth, we leverage our advanced DeepTech platform to enhance the development of an...
La Garriga, Spain
South San Francisco, Unit...
MOGAM Institute for Biomedical Research
Advancing global health with AI-driven therapies for rare diseases, autoimmune disorders,...
Seoul, Korea South
Angitia Biopharmaceuticals
Developing innovative medicines to address serious musculoskeletal diseases
Westlake Village, United...
About ENYO Pharma
ENYO Pharma is a biopharmaceutical company that focuses on developing therapeutics for diseases with impaired kidney function. The company's lead compound, Vonafexor, is currently undergoing Phase 2 trials for Chronic Kidney Diseases (CKD), rare kidney diseases such as Alport syndrome, and liver diseases, including Non...
Developing therapeutics for diseases with impaired kidney function
Patients with impaired kidney function, pharmaceutical companies, research institutions
Biopharmaceuticals, Therapeutics, Chronic Kidney Diseases, Rare Kidney Diseases, Liver Diseases, Infectious Diseases, Vonafexor, Intracellular Therapeutic Targets, Anti-virals, Drug Development, Phase 2 Trials, Research And Development, Inserm Patents, Viral Treatments, Global Leader
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches ENYO Pharma and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at ENYO Pharma on 11 Jun 2025. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
